共 50 条
Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia
被引:14
|作者:
Magierski, Radoslaw
[1
]
Sobow, Tomasz
[2
]
机构:
[1] Med Univ Lodz, Dept Old Age Psychiat & Psychot Disorders, Lodz, Poland
[2] Med Univ Lodz, Dept Med Psychol, Sterlinga St 5, PL-91425 Lodz, Poland
关键词:
dementia;
neuropsychiatric symptoms;
5-hydroxytryptamine;
Alzheimer's disease;
behavioral and psychological symptoms of dementia;
serotonin;
INAPPROPRIATE SEXUAL-BEHAVIOR;
MILD-COGNITIVE-IMPAIRMENT;
NURSING-HOME PATIENTS;
CANADIAN CONSENSUS CONFERENCE;
ALZHEIMERS-DISEASE;
DOUBLE-BLIND;
PSYCHOLOGICAL SYMPTOMS;
FRONTOTEMPORAL DEMENTIA;
REUPTAKE INHIBITORS;
ANTIDEPRESSANT USE;
D O I:
10.1586/14737175.2016.1155453
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Behavioral and psychological symptoms of dementia (known also as neuropsychiatric symptoms) are essential features of Alzheimer's disease and related dementias. The near universal presence of neuropsychiatric symptoms in dementia (up to 90% of cases) has brought significant attention of clinicians and experts to the field. Non-pharmacological and pharmacological interventions are recommended for various types of neuropsychiatric symptoms. However, most pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia are used off-label in many countries. Cognitive decline and neuropsychiatric symptoms can be linked to alterations in multiple neurotransmitter systems, so modification of abnormalities in specific systems may improve clinical status of patients with neuropsychiatric symptoms. Use of serotonergic compounds (novel particles acting on specific receptors and widely acting drugs) in the treatment of neuropsychiatric symptoms is reviewed.
引用
收藏
页码:375 / 387
页数:13
相关论文